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ABSTRACT
Background and Objectives: To evaluate the experi-
ence with laparoscopic nephrectomy in a large county
hospital and perform a cost comparison between uncom-
plicated open and laparoscopic nephrectomy.
Methods: Eleven consecutive patients who underwent
an uncomplicated laparoscopic nephrectomy in a large
county hospital were compared with 8 patients who
underwent uncomplicated open nephrectomy during the
same period. Patient charts and corresponding billing
records were reviewed to determine overall hospitaliza-
tion cost and individual cost components.
Results: No perioperative complications occurred in either
the laparoscopic or open group, and no statistically signif-
icant differences existed between groups with regard to
patient demographics or operative parameters. The overall
operating room costs favored the open nephrectomy
group by $1070 (P=0.003). However, the overall cost of
hospitalization, surgeon professional fees, duration of hos-
pitalization, room and board costs, laboratory, and radiol-
ogy costs, pharmacy costs, intravenous solution and infu-
sion pump costs all significantly favored the laparoscopic
patient group. The mean difference in overall hospital cost
between laparoscopic and open nephrectomy was $1211
in favor of laparoscopy (P=0.037).
Conclusions: Our experience with laparoscopic nephrec-
tomy in a large county hospital demonstrates a clear eco-
nomic advantage in favor of the laparoscopic approach.
Given limited funding for public hospitals and a clear
patient benefit, laparoscopic nephrectomy should consti-
tute first-line therapy when nephrectomy is indicated.
Key Words: Laparoscopic nephrectomy, Cost compari-
son.
INTRODUCTION
Since 1990 when Clayman and colleagues first performed
a laparoscopic nephrectomy for a 3-cm oncocytoma,1
published series have confirmed the feasibility and safe-
ty of performing the procedure for benign and malignant
lesions.2-11 The laparoscopic approach has been associ-
ated with a shorter length of hospital stay, decreased
requirements for pain medication and quicker recovery
in the postoperative period.2,3,6,8,9 Despite these advan-
tages, however, most centers have reported higher costs
for the laparoscopic approach due to longer operative
times and use of nonreusable equipment.2,9,10
Fiscal responsibility is mandatory in today’s health-care
environment, particularly at publicly funded institutions.
We performed a cost comparison between consecutive
cases of uncomplicated open and laparoscopic nephrec-
tomy at a large metropolitan county hospital and
assessed the individual cost centers to identify areas in
which we could increase the cost efficiency of the
laparoscopic approach.
MATERIALS AND METHODS
Eleven consecutive patients who underwent an uncompli-
cated laparoscopic nephrectomy in a large county hospital
were compared with 8 patients who underwent uncompli-
cated open nephrectomy during the same period. None of
these patients had a perioperative complication. Patient
characteristics and intraoperative parameters were
obtained including age, American Society of Anesthesio-
logists (ASA) class, specimen dimensions, tumor size, sur-
gery duration (time of first incision to surgery end time),
estimated blood loss (EBL), and complications. Patient
charts and billing records were then reviewed to determine
the total hospitalization cost for the procedure, taking into
account individual cost centers, hospital stay, and profes-
sional fees. Cost centers included operating room, surgical
supplies, room and board, pharmacy, intravenous fluids,
laboratory, radiology, and infusion pump fees. The infor-
mation obtained for each case was based on hospital cost
and not charge data.
Statistical analyses were performed with the Student t test
and the Mann-Whitney test when applicable. Statistical
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significance was assumed for P<0.05.
All laparoscopic procedures were supervised by 1 sur-
geon (J.A.C) with urology residents as the primary sur-
geons. Regardless of presumed pathology (benign vs
malignant), all patients underwent a radical nephrectomy
dissection. A transperitoneal laparoscopic approach was
used exclusively. Patients with a solid renal lesion under-
went intact specimen removal, whereas patients with pre-
sumed benign renal disease underwent specimen mor-
cellation.
The technique of transperitoneal laparoscopic nephrecto-
my has been previously described.12 Typically, a 3- or 4-
port approach was used: one 12-mm trocar was placed at
the umbilicus, one 12-mm port 2 fingerbreadths above
and medial to the anterior superior iliac spine, and one
5-mm port in the midline between the xiphoid process
and the umbilicus. Occasionally, a 5-mm upper midline
port was placed to facilitate liver retraction. Surgical spec-
imens were removed with a laparoscopic sack. For intact
specimen removal, the umbilical port incision was
extended. For specimen morcellation, a ringed-forceps or
Kelly clamp was used to extract the specimen piecemeal
through the umbilical port.
The laparoscopic procedure included the use of dispos-
able instruments including 12-mm trocars, Veress needle,
5-mm clip appliers, suction-irrigator, endo GIA, and
laparoscopic sack. All other instruments were reusable.
Open nephrectomy was performed with a variety of inci-
sions (flank incision=6, subcostal incision=2). These
operations were similarly supervised by staff urologists
with urology residents as the primary surgeon.
RESULTS
The laparoscopic and open nephrectomy groups were
comparable with regard to patient characteristics and
operative parameters (Tables 1 and 2). No intraopera-
tive or postoperative complications occurred in either
group. For patients with malignant disease, surgical mar-
gins were negative in both groups.
Table 3 compares the overall cost and individual cost
centers for the 2 groups. The overall cost, surgeon pro-
fessional fees, length of stay, room and board costs, lab-
oratory and radiology costs, pharmacy and intravenous
solution and infusion pump fees all favored the laparo-
scopic group (P<0.05). However, operating room cost
favored the open nephrectomy group over the laparo-
scopic group ($2487 vs $3557, respectively, (P=0.003).
The mean difference in overall hospital cost between
laparoscopic and open nephrectomy was $1211 in favor
of laparoscopy (P=0.037). The higher operating room
cost was more than offset by earlier discharge, faster
return to a regular diet, and less use of oral pain med-
ication in the laparoscopic compared with the open
group, which translated into cost savings with regard to
intravenous fluids, medication, and infusion pumps.
No statistically significant differences in total cost, opera-
tive time, or length of hospitalization were demonstrated
between patients undergoing a laparoscopic nephrecto-
my for benign and malignant disease. Similarly, no sig-
nificant differences in total cost or any cost center were
demonstrated between surgical approaches for open
nephrectomy.
Table 1.
Patient Demographics
Laparoscopic Nephrectomy Open Nephrectomy PValue*
Male 2 3 N/A
Female 9 5 N/A
Left side 7 4 N/A
Right side 4 4 N/A
Age 46.6 (26-63) 49.3 (30-62) 0.657
American Society of
Anesthesiologists (ASA) class 2.4 (2-3) 2.9 (2-3) 0.067†
*Student t test used for evaluation of P values unless otherwise specified.
†Mann-Whitney test.JSLS(2003)7:111-115 113
Table 2.
Operative Parameters
Laparoscopic Nephrectomy Open Nephrectomy PValue*
Mean (range) Mean (range)
Malignant 6 6 N/A
Benign 5 2 N/A
Surgery duration (min)† 185 (110-303) 174 (127-210) 0.582
Est.blood loss (cc) 382 (100-1100) 271 (100-650) 0.297‡
Specimen weight (g)§ 399 (149-553) 656 (260-1240) 0.151
Specimen dimensions:§
Length (cm) 15.4 (13-18) 14.3 (10-19) 0.427
Width (cm) 9.6 (7.5-12) 9.6 (7-15) 0.988
A-P (cm) 4.6 (4-5.5) 6.3 (3-9.5) 0.135
Tumor max diameter (cm) 4.7 (1.5-7.5) 8.3 (2-12) 0.083
*Student t test used for evaluation of P values unless otherwise specified.
†Surgery duration was from initial incision to surgery finish time.
‡Mann-Whitney test.
§ Specimen dimensions and weight did not include morcellated specimens.
Table 3.
Cost Analysis
Laparoscopic Nephrectomy Open Nephrectomy PValue*
Mean ± SD Mean ± SD
Overall cost
(hospital costs+professional fees) 7468 ± 1036 8679 ± 1195 0.037
Hospital costs (all inclusive) 5968 ± 977 6870 ± 1182 0.097
Anesthesiologist fees† 348 ± 64 335 ± 36 0.625
Surgeon’s fees‡ 1152 1474 <0.001§
Total OR (OR costs+supplies) 3557 ± 759 2487 ± 271 0.003§
OR costs 2435 ± 496 2332 ± 283 0.625
Surgical supplies 1122 ± 361  155 ± 65 <0.001§
Anesthesia costs (hospital) 229 ± 34 260 ± 37 0.075
Duration of hospitalization (days) 3.3 ± .91 6.1 ± 1.73 <0.001
Room and Board 1293 ± 357 2419 ± 682 <0.001
Studies (laboratory/radiology) 136 ± 31 255 ± 63 <0.001
Pharmacy (medications+supplies) 232 ± 110 484 ± 154 <0.001
Intravenous solutions 112 ± 66 315 ± 152 <0.001
Infusion pump 36 ± 24 93 ± 68 0.02
*Student t test used for evaluation of P values unless otherwise specified.
†Anesthesiologist fees based on Medicare reimbursement rates of $18/unit.
‡Surgeon’s fees based on Medicare reimbursement for year 2000.
§Mann-Whitney test.Laparoscopic Nephrectomy Is Cost Effective Compared With Open Nephrectomy in a Large County Hospital, Lotan Y et al.
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DISCUSSION
In the current cost-conscious medical environment, the
importance of fiscal responsibility rests heavily on physi-
cians. Although the feasibility, safety and advantage of
performing laparoscopic nephrectomy for benign and
malignant disease2-11 has been well established, the
laparoscopic approach has consistently been associated
with higher costs due to longer operative times and the
use of nonreusable equipment.2,9,20 Thus far, few cost
comparisons have been made between open and laparo-
scopic nephrectomy. Dunn and colleagues2 compared 5
uncomplicated laparoscopic and 5 open nephrectomies
and found that the laparoscopic approach was $2000
more costly because of longer operating room time and
higher equipment costs.2 Wolf and associates9 compared
the cost of laparoscopic and open live donor nephrecto-
my and noted that the mean operative cost was 73%
higher and the mean overall hospital cost was 23% high-
er in the laparoscopic group compared with that in the
open group (P<0.001 and P<0.005, respectively). The
shorter hospital stay and fewer interventions required in
the laparoscopic group partly compensated for the
increased operating room expenses. In contrast, Kou and
colleagues13 recently reported a cost advantage for
laparoscopic donor nephrectomy when the hospital stay
was less than 23 hours. When the hospital stay exceeded
23 hours, a cost advantage no longer existed for laparo-
scopic nephrectomy.
In the present study, the decrease in hospital stay, earlier
return to oral intake, and more rapid progression to oral
pain medication significantly reduced the overall cost in
favor of laparoscopy by offsetting the increased cost of
laparoscopic equipment. In addition, our comparable
open and laparoscopic operating room surgical times
eliminated the cost advantage for open nephrectomy
seen in other series. At our institution, the cost of one 30-
minute increment of operating room time is $280, and
Medicare reimbursement for anesthesiologist professional
fees is $18 per 15-minute increment. Thus, each addi-
tional hour of operating time would translate into an
additional $632 incremental cost.
Our outcomes for laparoscopy are comparable to those
reported in the literature. Gill and coworkers3 compared
their extensive laparoscopic nephrectomy experience
with a contemporary open nephrectomy group and noted
a length of stay advantage similar to ours (1.4 vs 5.8 days
for the laparoscopic and open patients, respectively).
Likewise, our mean operative time was consistent with
many reported in the literature for retroperitoneal (145-
211 minutes3,4,8) and transperitoneal laparoscopic
nephrectomy (207 minutes).8 In 2 recent series, howev-
er, operative times of 354 minutes2 and 312 minutes6
were reported. These longer operating times reflect the
extensive 5-6 and 9-year2 experiences of the authors,
including the initial learning curves.
Although the specimen weight in our study was greater
for the open compared with the laparoscopic group, the
difference did not reach statistical significance. However,
specimen weights were limited to the intact specimens
and the sample size for the laparoscopic group was
small. The specimen dimension and maximum tumor
diameter were not statistically different between the 2
groups. Both Gill et al3 and Abbou et al4 reported larger
tumor sizes in their open nephrectomy groups compared
with the laparoscopic nephrectomy groups, but the dif-
ferences were not statistically significant. Currently, we
remove potential neoplasms through an extension of the
umbilical port site and have not been significantly limit-
ed by the size of specimens.
We acknowledge several limitations to our study. First,
institutional costs differ, and this outcome could be insti-
tution-dependent. Although the various cost parameters
may differ among institutions, the contribution of earlier
discharge, earlier return to oral intake, and less pain
medication should be universal. The cost of complica-
tions was not considered in our evaluation. Cadeddu and
coworkers5 reported a 9.6% rate of perioperative compli-
cations in a multicenter retrospective study of 157
patients. Other studies that compared the complication
rates between open and laparoscopic nephrectomy
found either no significant difference9,10 or fewer com-
plications in the laparoscopic group.2-4 These results sug-
gest that adding complication costs would not signifi-
cantly alter the outcome of our cost comparison or
would further favor laparoscopy. This study also includ-
ed a relatively small number of patients. However, the
overall costs varied by a similar standard deviation of
approximately $1000, and no patients were significant
outliers. This study primarily addressed a comparison of
patients with uncomplicated hospital courses so it is
unlikely that any given patient would significantly devi-
ate from the mean.
The results of this study demonstrate that in this era of
cost containment, laparoscopic nephrectomy offers bothJSLS(2003)7:111-115 115
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direct and indirect cost advantages over open nephrec-
tomy. In addition to a lower overall cost for hospitaliza-
tion for laparoscopic nephrectomy, Dunn et al2 noted
that patients undergoing laparoscopy return to work
sooner, an economic advantage that is difficult to quan-
tify but nonetheless has a significant impact on the econ-
omy and community as a whole. The economic as well
as clinical advantages of laparoscopic nephrectomy
should serve as a strong impetus to expand the avail-
ability and utilization of laparoscopy as a surgical option
for patients at other institutions with fixed funding.
CONCLUSIONS
In reviewing a county hospital experience with laparo-
scopic and open nephrectomy, a clear economic advan-
tage was demonstrated for laparoscopic nephrectomy.
Adding this to the already established advantages of
more rapid convalescence, quicker return to oral intake,
less pain medication, and less postoperative pain, laparo-
scopic nephrectomy should be offered to all eligible
patients, regardless of whether the institution is private or
public.
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